BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 19432296)

  • 1. The treatment of stage A testicular seminoma by carboplatin monochemotherapy.
    Bojanić N; Mićić S; Vuksanović A; Vuković I; Janjić A
    Vojnosanit Pregl; 2009 Apr; 66(4):303-6. PubMed ID: 19432296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant carboplatin treatment for seminoma clinical stage I.
    Dieckmann KP; Krain J; Küster J; Brüggeboes B
    J Cancer Res Clin Oncol; 1996; 122(1):63-6. PubMed ID: 8543595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment outcome and patterns of relapse following adjuvant carboplatin for stage I testicular seminomatous germ-cell tumour: results from a 17-year UK experience.
    Chau C; Cathomas R; Wheater M; Klingbiel D; Fehr M; Bennett J; Markham H; Lee C; Crabb SJ; Geldart T
    Ann Oncol; 2015 Sep; 26(9):1865-1870. PubMed ID: 26037797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of clinical stage I testicular pure seminoma. Report on 42 patients and review of the literature.
    Porcaro AB; Antoniolli SZ; Schiavone D; Maffei N; Bassetto MA; Curti P
    Arch Ital Urol Androl; 2002 Jun; 74(2):77-80. PubMed ID: 12161941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase II study: adjuvant single-agent carboplatin therapy for clinical stage I seminoma.
    Krege S; Kalund G; Otto T; Goepel M; Rübben H
    Eur Urol; 1997; 31(4):405-7. PubMed ID: 9187898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term experience with carboplatin monotherapy for clinical stage I seminoma: a retrospective single-center study.
    Steiner H; Höltl L; Wirtenberger W; Berger AP; Bartsch G; Hobisch A
    Urology; 2002 Aug; 60(2):324-8. PubMed ID: 12137835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retrospective multicentre study of carboplatin monotherapy for clinical stage I seminoma.
    Steiner H; Scheiber K; Berger AP; Rein P; Hobisch A; Aufderklamm J; Pilloni S; Stoehr B; Aigner F; Fritzer A; Zangerl F
    BJU Int; 2011 Apr; 107(7):1074-9. PubMed ID: 21438975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of testicular seminoma advanced disease. Report on 14 cases and review of the literature.
    Porcaro AB; Antoniolli SZ; Maffei N; Beltrami P; Bassetto MA; Curti P
    Arch Ital Urol Androl; 2002 Jun; 74(2):81-5. PubMed ID: 12161942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Twelve-year experience with two courses of adjuvant single-agent carboplatin therapy for clinical stage I seminoma.
    Reiter WJ; Brodowicz T; Alavi S; Zielinski CC; Kozak W; Maier U; Nöst G; Lipsky H; Marberger M; Kratzik C
    J Clin Oncol; 2001 Jan; 19(1):101-4. PubMed ID: 11134201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk-adapted management for patients with clinical stage I seminoma: the Second Spanish Germ Cell Cancer Cooperative Group study.
    Aparicio J; Germà JR; García del Muro X; Maroto P; Arranz JA; Sáenz A; Barnadas A; Dorca J; Gumà J; Olmos D; Bastús R; Carles J; Almenar D; Sánchez M; Paz-Ares L; Satrústegui JJ; Mellado B; Balil A; López-Brea M; Sánchez A;
    J Clin Oncol; 2005 Dec; 23(34):8717-23. PubMed ID: 16260698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sperm analysis and serum follicle-stimulating hormone levels before and after adjuvant single-agent carboplatin therapy for clinical stage I seminoma.
    Reiter WJ; Kratzik C; Brodowicz T; Haitel A; Pokorny A; Zielinski CC; Marberger M
    Urology; 1998 Jul; 52(1):117-9. PubMed ID: 9671881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Risk-Adapted Approach to Patients with Stage I Seminoma according to the Status of Rete Testis: The Fourth Spanish Germ Cell Cancer Group Study.
    Aparicio J; Sánchez-Muñoz A; Gumà J; Domenech M; Meana JA; García-Sánchez J; Bastús R; Gironés R; González-Billalabeitia E; Sagastibelza N; Ochenduszko S; Sánchez A; Terrasa J; Germà-Lluch JR; García Del Muro X;
    Oncology; 2018; 95(1):8-12. PubMed ID: 29587278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carboplatin does not prevent contralateral testicular tumors in patients with seminoma.
    Dieckmann KP; Matthies C; Kliesch S
    J Clin Oncol; 2011 Jul; 29(21):2944-5; author reply 2945-6. PubMed ID: 21670458
    [No Abstract]   [Full Text] [Related]  

  • 14. Adjuvant Carboplatin Treatment in 115 Patients With Stage I Seminoma: Retrospective Multicenter Survey.
    Diminutto A; Basso U; Maruzzo M; Morelli F; De Giorgi U; Perin A; Fraccon AP; Lo Re G; Rizzi A; Sava T; Fornarini G; Valcamonico F; Zustovich F; Massari F; Zanardi E; Roma A; Zattoni F; Zagonel V
    Clin Genitourin Cancer; 2016 Apr; 14(2):e161-9. PubMed ID: 26775721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk-adapted treatment in clinical stage I testicular seminoma: the third Spanish Germ Cell Cancer Group study.
    Aparicio J; Maroto P; del Muro XG; Gumà J; Sánchez-Muñoz A; Margelí M; Doménech M; Bastús R; Fernández A; López-Brea M; Terrassa J; Meana A; del Prado PM; Sastre J; Satrústegui JJ; Gironés R; Robert L; Germà JR
    J Clin Oncol; 2011 Dec; 29(35):4677-81. PubMed ID: 22042940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiotherapy versus single-dose carboplatin in adjuvant treatment of stage I seminoma: a randomised trial.
    Oliver RT; Mason MD; Mead GM; von der Maase H; Rustin GJ; Joffe JK; de Wit R; Aass N; Graham JD; Coleman R; Kirk SJ; Stenning SP;
    Lancet; 2005 Jul 23-29; 366(9482):293-300. PubMed ID: 16039331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single agent carboplatin for CS IIA/B testicular seminoma. A phase II study of the German Testicular Cancer Study Group (GTCSG).
    Krege S; Boergermann C; Baschek R; Hinke A; Pottek T; Kliesch S; Dieckmann KP; Albers P; Knutzen B; Weinknecht S; Schmoll HJ; Beyer J; Ruebben H;
    Ann Oncol; 2006 Feb; 17(2):276-80. PubMed ID: 16254023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carboplatin for stage I seminoma and the sword of Damocles.
    Loehrer PJ; Bosl GJ
    J Clin Oncol; 2005 Dec; 23(34):8566-9. PubMed ID: 16260692
    [No Abstract]   [Full Text] [Related]  

  • 19. Carboplatin AUC 10 for IGCCCG good prognosis metastatic seminoma.
    Tookman L; Rashid S; Matakidou A; Phillips M; Wilson P; Ansell W; Jamal-Hanjani M; Chowdhury S; Harland S; Sarwar N; Oliver T; Powles T; Shamash J
    Acta Oncol; 2013 Jun; 52(5):987-93. PubMed ID: 22943385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful treatment of stage-IIIB seminoma with single-agent carboplatin therapy.
    Bohle W; Ruether U; Rassweiler J; Nunnensiek C; Eisenberger F; Jipp P
    Urol Int; 1997; 59(1):53-4. PubMed ID: 9313327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.